Search results

Skip to results

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Showing 1 to 2 of 2 results for crovalimab

  1. Crovalimab for treating paroxysmal nocturnal haemoglobinuria in people 12 years and over (TA1019)

    Evidence-based recommendations on crovalimab (Piasky) for paroxysmal nocturnal haemoglobinuria in people 12 years and over.

    Technology appraisal guidance
    Published
    20 November 2024
    View recommendations

    Sections for TA1019

  2. Crovalimab for treating atypical haemolytic uraemic syndrome [TSID12386]

    Awaiting development Reference number: GID-TA12006 Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development